Returning from CPhI 2019, in Frankfurt, the words of Eric Langer, President of Bioplan Associates, have stuck with me. Forget the innovation, are biosimilars the real 'workhorse' carrying biopharma to bigger and better things?
Pharma packaging is in transition. Companies are now pushing boundaries, furthering their offerings and innovating to be seen as true healthcare partners.
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
In an industry as fast paced as the specialty chemicals sector, it's almost impossible to predict the future, but we wanted to try.
Identifying the next big trend in a market like specialty chemicals can be gold dust for any company or individual savvy enough to see it.
In today's hyper-connected world, what's the point of conferences? Our Associate Director Jack Shute asked experts from across the speciality chemical space and some of his CM Life Science colleagues to find out.
It’s no secret that pharmaceutical manufacturing has been on the rise in the East, with both China and India emerging as major manufacturing hubs.
The diverse and complex world of Pharmaceuticals and Contract Development and Manufacturing Organization (CDMO) is undergoing a fascinating transition.
There are a lot of people and organisations who rank Contract/Clinical Research Organisations. Not only that, but they do it extremely well. That’s why the tables and rankings that appear so regularly on our newsfeeds are so popular.
